Abstract:Abstract Background Crohn’s disease (CD) is characterized by chronic inflammation that can discontinuously affect any segment of the gastrointestinal tract. New findings concerning clinical behaviour, epidemiology, genetics, and gut microbiota suggest that CD in the ileum (iCD) and the colon (cCD) should be considered as two distinct subtypes of IBD. As systemic immune cell signatures differ between CD and UC, we propose a similar strategy for the differentiation between iCD and cCD. The aim of this study is to analyse and compare peripheral blood mononuclear cell (PBMC) subsets of iCD and cCD patients. For a robust analysis of the peripheral immune compartment in inflammatory bowel diseases (IBD), PBMC subsets of ileocolonic CD (icCD), ulcerative colitis (UC) and healthy controls (HC) were included as well. Methods In this study a total of 50 adults, 10 subjects per subgroup – iCD, cCD, icCD, UC and HC – were included. From each individual, both naïve and PMA/Ionomycin stimulated samples were stained for phenotypic and functional characterization using mass cytometry. For data analysis pre-gating was performed in Cytobank followed by debarcoding, compensation, normalization, clustering, and analysis on differential abundances edge R (DA_edgeR) and differential states limma (DS_limma) with CATALYST in R. Results FlowSOM allowed us to cluster CD45+ PBMCs of all samples into 16 major cell subtypes as visualized via UMAP (Fig. 1). DA testing showed significant differences between iCD and cCD, iCD and icCD but not cCD and icCD (Fig 2). Significantly different abundances among CD subgroups and HC included cluster 1 CD33+ myeloid cells, 7 CD45RO+ CD16+ cells, 8 CD11b+ cells, 9 CD4+ IL7R+ T cells and 12 CD27+ CD38+ CD45RA+ B cells (Fig. 3). When focussing on differences between iCD, cCD and icCD, DS testing revealed significantly higher IFNgamma and TNFalpha production in cluster 9 (CD4+ IL7R+ T cells), 15 (CD8+ T cells) and 16 (CD8+ CD45RO+ T cells) in iCD compared to icCD. Moreover, cluster 9 showed significantly higher levels of IFNgamma in iCD compared to cCD, and for TNFalpha cluster 16 revealed significantly higher levels in cCD compared to icCD (Fig. 4). Fig. 1 UMAP clustering of stimulated cells. Fig. 2 Differential analysis of stimulated samples with DA_edgeR and DS_limma. Fig. 3 Relative population abundances with DA_edge R testing. Fig. 4 Relative state marker abundance within clusters with DS_limma testing. Conclusion Deep phenotyping of the peripheral immune cell compartment in CD might serve as a confirmatory marker for disease location and therefore as predictor of clinical behaviour.

Alterations of Peripheral Blood CD5+ B Cells in Inflammatory Bowel Disease.

CD177+ Neutrophils and Its Correlation with Mucosal Impairment in Patients with Inflammatory Bowel Disease

CD4 T-Cell Subsets and the Pathophysiology of Inflammatory Bowel Disease

Immune Regulatory Mechanisms of CD177+ Neutrophils in the Pathogenesis of Inflammatory Bowel Disease

Clinical Evaluation of Lung Function in 74 Patients with Inflammatory Bowel Disease

Potential Role of Th17 Cells in the Pathogenesis of Inflammatory Bowel Disease.

Hyperactivated B Cells in Human Inflammatory Bowel Disease

The role of CD19+ CD5+ CD1dhi B cells in dextran sulfact sodium (DSS)

Antigen-driven expansion of public clonal T cell populations in inflammatory bowel diseases

Stromal-like Cells Are Found in Peripheral Blood of Inflammatory Bowel Disease Patients and Correlate with Immune Activation State

Cytotoxic T Lymphocyte-associated Antigen 4 Expression on Surface of Peripheral Blood Mononuclear Cells in Patients with Inflammatory Bowel Disease

P048 Deep phenotyping of the peripheral immune cell compartment in Crohn‘s Disease

The Role of CD19+CD5+CD1dhi B Cells in Dextran Sulfact Sodium (dss)induced Inflammatory Bowel Disease C57BL/6 Mouse Model

Increased Expression of Costimulatory Molecules on Peripheral Blood Monocytes in Patients with Crohn's Disease

Alterations of Th17/Treg Cells in Peripheral Blood and Serum Inflammatory Biomarkers in Patients with Crohn's Disease and Its Clinical Significance

Ulcerative Colitis is Characterized by a Decrease in Regulatory B Cells.

Activation of CD40-CD154 Co-Stimulatory Pathway and Its Correlation with Disease Activity in Patients with Inflammatory Bowel Disease

Systemic Toll-like Receptor Ligands Modify B-cell Responses in Human Inflammatory Bowel Disease.

Alterations of pulmonary function in patients with inflammatory bowel diseases

Increased Expression of CCL20 in Human Inflammatory Bowel Disease

Lipidomic Profiling in Inflammatory Bowel Disease